| Ramakrishnayya Gadam, MD | |
|
3264 N Evergreen Drive Ne, Grand Rapids, MI 49525 | |
| (616) 363-7272 | |
| (616) 361-5828 |
| Full Name | Ramakrishnayya Gadam |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 53 Years |
| Location | 3264 N Evergreen Drive Ne, Grand Rapids, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053381723 | NPI | - | NPPES |
| 4306125 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 4301038507 (Michigan) | Primary |
| 2085N0904X | Radiology - Nuclear Radiology | 4301038507 (Michigan) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Covenant Medical Center | Saginaw, MI | Hospital |
| Spectrum Health | Grand rapids, MI | Hospital |
| Midmichigan Medical Center-midland | Midland, MI | Hospital |
| Mclaren Bay Region | Bay city, MI | Hospital |
| Midmichigan Medical Center-gratiot | Alma, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Advanced Radiology Services Pc | 4284546516 | 235 |
| Spartan Radiology Inc | 5698003697 | 179 |
| Spartan Radiology Inc | 5698003697 | 179 |
News Archive
HHS Secretary Kathleen Sebelius today highlighted the benefits of health insurance reform for businesses and released a new fact sheet regarding a recent analysis from the Congressional Budget Office.
AbbVie announced today the initiation of a Phase 3 clinical study called SONAR (Study Of Diabetic Nephropathy with Atrasentan) to assess the effects of the investigational compound atrasentan - when added to standard of care - on progression of kidney disease in patients with stage 2 to 4 chronic kidney disease and type 2 diabetes.
Updated guidelines on nutrition and physical activity for cancer prevention from the American Cancer Society stress the importance of creating social and physical environments that support healthy behaviors. The report includes updated recommendations for individual choices regarding diet and physical activity patterns, but emphasizes that those choices occur within a community context that can either help or hinder healthy behaviors.
Tocagen Inc., a clinical-stage immuno-oncology company, today announced that the U.S. Food and Drug Administration has granted orphan drug designation to the company's lead immuno-oncology product candidate, Toca 511 & Toca FC, for the treatment of glioblastoma.
› Verified 1 days ago
| Entity Name | Advanced Radiology Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740283324 PECOS PAC ID: 4284546516 Enrollment ID: O20031104000494 |
News Archive
HHS Secretary Kathleen Sebelius today highlighted the benefits of health insurance reform for businesses and released a new fact sheet regarding a recent analysis from the Congressional Budget Office.
AbbVie announced today the initiation of a Phase 3 clinical study called SONAR (Study Of Diabetic Nephropathy with Atrasentan) to assess the effects of the investigational compound atrasentan - when added to standard of care - on progression of kidney disease in patients with stage 2 to 4 chronic kidney disease and type 2 diabetes.
Updated guidelines on nutrition and physical activity for cancer prevention from the American Cancer Society stress the importance of creating social and physical environments that support healthy behaviors. The report includes updated recommendations for individual choices regarding diet and physical activity patterns, but emphasizes that those choices occur within a community context that can either help or hinder healthy behaviors.
Tocagen Inc., a clinical-stage immuno-oncology company, today announced that the U.S. Food and Drug Administration has granted orphan drug designation to the company's lead immuno-oncology product candidate, Toca 511 & Toca FC, for the treatment of glioblastoma.
› Verified 1 days ago
| Entity Name | Advanced Diagnostic Imaging Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245299494 PECOS PAC ID: 3779489224 Enrollment ID: O20031208000473 |
News Archive
HHS Secretary Kathleen Sebelius today highlighted the benefits of health insurance reform for businesses and released a new fact sheet regarding a recent analysis from the Congressional Budget Office.
AbbVie announced today the initiation of a Phase 3 clinical study called SONAR (Study Of Diabetic Nephropathy with Atrasentan) to assess the effects of the investigational compound atrasentan - when added to standard of care - on progression of kidney disease in patients with stage 2 to 4 chronic kidney disease and type 2 diabetes.
Updated guidelines on nutrition and physical activity for cancer prevention from the American Cancer Society stress the importance of creating social and physical environments that support healthy behaviors. The report includes updated recommendations for individual choices regarding diet and physical activity patterns, but emphasizes that those choices occur within a community context that can either help or hinder healthy behaviors.
Tocagen Inc., a clinical-stage immuno-oncology company, today announced that the U.S. Food and Drug Administration has granted orphan drug designation to the company's lead immuno-oncology product candidate, Toca 511 & Toca FC, for the treatment of glioblastoma.
› Verified 1 days ago
| Entity Name | Covenant Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972590412 PECOS PAC ID: 2769387778 Enrollment ID: O20031209000107 |
News Archive
HHS Secretary Kathleen Sebelius today highlighted the benefits of health insurance reform for businesses and released a new fact sheet regarding a recent analysis from the Congressional Budget Office.
AbbVie announced today the initiation of a Phase 3 clinical study called SONAR (Study Of Diabetic Nephropathy with Atrasentan) to assess the effects of the investigational compound atrasentan - when added to standard of care - on progression of kidney disease in patients with stage 2 to 4 chronic kidney disease and type 2 diabetes.
Updated guidelines on nutrition and physical activity for cancer prevention from the American Cancer Society stress the importance of creating social and physical environments that support healthy behaviors. The report includes updated recommendations for individual choices regarding diet and physical activity patterns, but emphasizes that those choices occur within a community context that can either help or hinder healthy behaviors.
Tocagen Inc., a clinical-stage immuno-oncology company, today announced that the U.S. Food and Drug Administration has granted orphan drug designation to the company's lead immuno-oncology product candidate, Toca 511 & Toca FC, for the treatment of glioblastoma.
› Verified 1 days ago
| Entity Name | Great Lakes Bay Health Centers |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871684761 PECOS PAC ID: 2466369046 Enrollment ID: O20040126000171 |
News Archive
HHS Secretary Kathleen Sebelius today highlighted the benefits of health insurance reform for businesses and released a new fact sheet regarding a recent analysis from the Congressional Budget Office.
AbbVie announced today the initiation of a Phase 3 clinical study called SONAR (Study Of Diabetic Nephropathy with Atrasentan) to assess the effects of the investigational compound atrasentan - when added to standard of care - on progression of kidney disease in patients with stage 2 to 4 chronic kidney disease and type 2 diabetes.
Updated guidelines on nutrition and physical activity for cancer prevention from the American Cancer Society stress the importance of creating social and physical environments that support healthy behaviors. The report includes updated recommendations for individual choices regarding diet and physical activity patterns, but emphasizes that those choices occur within a community context that can either help or hinder healthy behaviors.
Tocagen Inc., a clinical-stage immuno-oncology company, today announced that the U.S. Food and Drug Administration has granted orphan drug designation to the company's lead immuno-oncology product candidate, Toca 511 & Toca FC, for the treatment of glioblastoma.
› Verified 1 days ago
| Entity Name | Spartan Radiology Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932768058 PECOS PAC ID: 5698003697 Enrollment ID: O20190829001596 |
News Archive
HHS Secretary Kathleen Sebelius today highlighted the benefits of health insurance reform for businesses and released a new fact sheet regarding a recent analysis from the Congressional Budget Office.
AbbVie announced today the initiation of a Phase 3 clinical study called SONAR (Study Of Diabetic Nephropathy with Atrasentan) to assess the effects of the investigational compound atrasentan - when added to standard of care - on progression of kidney disease in patients with stage 2 to 4 chronic kidney disease and type 2 diabetes.
Updated guidelines on nutrition and physical activity for cancer prevention from the American Cancer Society stress the importance of creating social and physical environments that support healthy behaviors. The report includes updated recommendations for individual choices regarding diet and physical activity patterns, but emphasizes that those choices occur within a community context that can either help or hinder healthy behaviors.
Tocagen Inc., a clinical-stage immuno-oncology company, today announced that the U.S. Food and Drug Administration has granted orphan drug designation to the company's lead immuno-oncology product candidate, Toca 511 & Toca FC, for the treatment of glioblastoma.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ramakrishnayya Gadam, MD 3264 N Evergreen Drive Ne, Grand Rapids, MI 49525 Ph: (616) 363-7272 | Ramakrishnayya Gadam, MD 3264 N Evergreen Drive Ne, Grand Rapids, MI 49525 Ph: (616) 363-7272 |
News Archive
HHS Secretary Kathleen Sebelius today highlighted the benefits of health insurance reform for businesses and released a new fact sheet regarding a recent analysis from the Congressional Budget Office.
AbbVie announced today the initiation of a Phase 3 clinical study called SONAR (Study Of Diabetic Nephropathy with Atrasentan) to assess the effects of the investigational compound atrasentan - when added to standard of care - on progression of kidney disease in patients with stage 2 to 4 chronic kidney disease and type 2 diabetes.
Updated guidelines on nutrition and physical activity for cancer prevention from the American Cancer Society stress the importance of creating social and physical environments that support healthy behaviors. The report includes updated recommendations for individual choices regarding diet and physical activity patterns, but emphasizes that those choices occur within a community context that can either help or hinder healthy behaviors.
Tocagen Inc., a clinical-stage immuno-oncology company, today announced that the U.S. Food and Drug Administration has granted orphan drug designation to the company's lead immuno-oncology product candidate, Toca 511 & Toca FC, for the treatment of glioblastoma.
› Verified 1 days ago
Dr. Jon R Henke, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 3264 N Evergreen Dr Ne, Grand Rapids, MI 49525 Phone: 616-363-7272 Fax: 616-363-7290 | |
Geoffrey M. Remes, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3264 N Evergreen Dr Ne, Grand Rapids, MI 49525 Phone: 616-363-7339 Fax: 616-361-5828 | |
Jan L Mourelatos, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3264 N Evergreen Dr Ne, Grand Rapids, MI 49525 Phone: 616-363-7272 Fax: 616-361-5828 | |
Dr. Brendan Michael Banyon, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3264 N Evergreen Dr Ne, Grand Rapids, MI 49525 Phone: 616-363-7272 | |
Dr. Joseph J Junewick, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 3264 N Evergreen Dr Ne, Grand Rapids, MI 49525 Phone: 616-363-7272 Fax: 616-363-7290 | |
Keith Alan Morrow, D.O. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3264 N Evergreen Dr Ne, Grand Rapids, MI 49525 Phone: 616-363-7339 Fax: 616-361-5828 | |
Dr. Andrew Kent Moriarity, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3264 N Evergreen Dr Ne, Grand Rapids, MI 49525 Phone: 616-363-7339 |